Lori Silveira

Lori Silveira

Auto-generated profile, based on publicly available information

Lori Silveira

Department of Pediatrics, Section of Pediatric Endocrinology, University of Colorado, Aurora, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Open access
MKMary D. Klinnert
Mary D. Klinnert
LSLori Silveira
Lori Silveira
RHRachel Harris
Rachel Harris
WMWendy Moore
Wendy Moore
DADan Atkins
Dan Atkins
GFGlenn Furuta
Glenn Furuta
Objectives: Existing treatments for pediatric eosinophilic esophagitis (EoE) effectively reduce inflammation. The impact of treatment on health‐related quality of life (HRQoL) over time for pediatric patients with EoE and their families, however, has not been systematically assessed. We hypothesized that individualized multidisciplinary treatment would improve both child and family HRQoL over time, with improvements associated with decreased symptom severity.Methods: Children with EoE treated in 4 tertiary care centers were enrolled. Baseline assessments occurred at the time of patients' first evaluation; follow‐up assessments occurred at 2 and 6 months after baseline. Presence and severity of 8 EoE symptoms were measured. HRQoL was measured with the Pediatric Quality of Life Inventory parent proxy report, child self‐report (CR), and Family Impact Module (FIM). Statistical analyses used mixed‐effects modeling to test changes over time for child and family HRQoL.Results: Ninety‐seven children were enrolled (ages 2–18 years, mean age 7.7 years ± 4.8, 78% boys, 80% white). Baseline mean symptom number was 3.5 (standard deviation 2.3), and symptom severity was 5.5 (standard deviation, 4.5). HRQoL scores were significantly related to symptom scores (P < 0.001). EoE symptom severity decreased during the study (P = 0.03). Pediatric Quality of Life Inventory parent proxy Total and FIM Total scores improved from baseline to 6 months (respectively, adjusted means 78.4 vs 81.0, P = 0.0006; 68.9 vs 70.1, P = 0.03). Interactions with baseline symptom severity revealed that subjects with lowest symptom severity showed the most improved HRQoL scores (P = 0.0013).Conclusions: HRQoL improved during the course of evaluation and treatment, with positive changes being strongest for patients with less symptom severity at baseline.

22 September 2023 in Children and Youth Services Review
Verified
Journal Article
Closed access
GDGretchen J. Domek
Gretchen J. Domek
LSLauren Heller Szafran
Lauren Heller Szafran
MAMandy A. Allison
Mandy A. Allison
AKAllison Kempe
Allison Kempe
AJAndrea Monica Jimenez-Zambrano
Andrea Monica Jimenez-Zambrano
BCBonnie W. Camp
Bonnie W. Camp

1 January 2022 in The Journal of Pediatric Pharmacology and Therapeutics
Verified
Journal Article
Open access
PDF file
SLSterling Lee
Sterling Lee
ARAshley Reid
Ashley Reid
STSuhong Tong
Suhong Tong
LSLori Silveira
Lori Silveira
JTJames J. Thomas
James J. Thomas
MMMelissa M. Masaracchia
Melissa M. Masaracchia
OBJECTIVE: Pediatric patients with sleep-disordered breathing (SDB) and obesity are at risk for opioid-induced respiratory depression. Although monitoring in the inpatient setting allows for early recognition of opioid-related adverse events, there is far less vigilance after ambulatory surgery as patients are discharged home. Guidelines for proper opioid dosing in these pediatric subsets have not been established. We sought to determine if at-risk children were more likely to receive doses of opioids outside the recommended range. METHODS: Baseline opioid prescribing data for all outpatient surgery patients receiving an opioid prescription between January 2019 and June 2020 were retrospectively reviewed. Patients with SDB or obesity were identified. To obtain more information about prescribing practices, we analyzed patient demographics, size descriptors used for calculations, and prescription characteristics (dose, duration, and prescribing surgical service). RESULTS: A total of 4674 patients received an opioid prescription after outpatient surgery. Of those, 173 patients had SDB and 128 were obese. Surgical subspecialties rendering most of the opioid prescriptions included otolaryngology and orthopedics. Obese patients were more likely (64%) to be prescribed opioids using ideal weight at higher mg/kg doses (>0.05 mg/kg; 83.3%; p < 0.0001). When providers used actual body weight, lower mg/kg doses were more likely to be used (53.7%; p < 0.0001). No prescriptions used lean body mass. CONCLUSIONS: Overweight/obese children were more likely to receive opioid doses outside the recommended range. Variability in prescribing patterns demonstrates the need for more detailed guidelines to minimize the risk of opioid-induced respiratory complications in vulnerable pediatric populations.

6 April 2023 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
GDGretchen J. Domek
Gretchen J. Domek
LSLori Silveira
Lori Silveira
HKHelene Kuffel
Helene Kuffel
LSLauren Heller Szafran
Lauren Heller Szafran
AJAndrea Monica Jimenez-Zambrano
Andrea Monica Jimenez-Zambrano
BCBonnie W. Camp
Bonnie W. Camp
Positive relational experiences during infancy have a profound impact on child development and are critical for future health and school readiness. We have been evaluating a simple finger puppet intervention that takes one minute and costs $1USD to deliver in the primary care setting to promote caregiver-infant interactions. We explored using developmental trajectories to determine later outcomes of our early intervention program by comparing trajectories to age 36 months to assess optimal intervention timing when delivered in early versus late infancy. Three cohorts were enrolled and given a puppet at 2 months (early intervention) and 6 or 12 months (late intervention). Child development was assessed using the Ages & Stages Questionnaires (ASQ-3), which were independently collected during well visits. Scanned ASQ-3 forms from 2 to 36 months were obtained retrospectively through the electronic medical record. To compare longitudinal scores at different ages, all raw scores were first converted to z-scores. Longitudinal mixed effects models examined the trajectories of participant ASQ-3 scores over time by comparing the average intercepts and slopes. Of 180 children enrolled, 172 (96%) completed 2 or more ASQ-3 questionnaires and were included in the analysis, with a mean of 4.9 and a total of 843 questionnaires. Most children (85%) were on government-sponsored insurance. There were no statistical differences comparing cohort intercepts, while early intervention had a significant difference in slope compared to late intervention for the Personal-Social domain (0.12, p=0.018), resulting in higher predicted scores at 36 months. Early compared to late intervention had a difference in slope approaching significance for Communication (0.14, p=0.056) and the combined non-motor score (0.33, p=0.052). There were no significant differences in slope for Problem Solving (0.05, p=0.48), Gross Motor (-0.009, p=0.84), Fine Motor (0.06, p=0.22), and total ASQ-3 (0.32, p=0.17) scores. Finger puppets may provide a simple and scalable way to encourage responsive caregiver-infant interactions promoting language and social-emotional development, especially when provided in early versus late infancy. Our trajectory analysis also demonstrates a useful and potentially cost-effective approach to evaluating long-term developmental outcomes of an early intervention.

17 February 2026 in Epilepsy & Behavior
Verified
Journal Article
Closed access
KEKrista Eschbach
Krista Eschbach
LSLori Silveira
Lori Silveira
ESEmily M. Spelbrink
Emily M. Spelbrink
EWElaine Wirrell
Elaine Wirrell
SBSonal Bhatia
Sonal Bhatia
NLNatasha N. Ludwig
Natasha N. Ludwig

8 September 2026 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
JHJohan L K Van Hove
Johan L K Van Hove
MFMarisa W Friederich
Marisa W Friederich
RHRoxanne A Van Hove
Roxanne A Van Hove
JLJessica C Lee
Jessica C Lee
KKKaz M Knight
Kaz M Knight
JYJennifer H Yang
Jennifer H Yang
Genome sequencing is the first-line diagnostic method for primary mitochondrial diseases (PMDs), yet its effectiveness is limited by variants of uncertain significance or unresolved genetic findings. We systematically evaluated the clinical performance of fibroblast-based functional testing, comprised of respiratory chain enzyme assays, blue native polyacrylamide gel electrophoresis with in-gel activity staining (BN-PAGE), complex I assembly assay, and targeted protein abundance assessments, in a cohort of 204 genetically confirmed PMD patients, 51 healthy controls, and 53 patients with differential diagnoses. Individually, enzyme assays, BN-PAGE, and complex I assembly assay showed sensitivities of 46%, 40%, and 49%, with specificities of 93%, 98%, and 99%, respectively. Combined, the assays achieved an overall sensitivity of 76%, a specificity 93%, a positive predictive value 96%, and a negative predictive value of 67%. Sensitivity was highest for isolated respiratory chain deficiencies, nuclear DNA-encoded mitochondrial translation defects, cofactor deficiencies, and mitochondrial aminoacyl-tRNA synthetase disorders, whereas mitochondrial DNA variants and maintenance defects remained challenging. Secondary mitochondrial dysfunction was rare. The strong clinical utility of comprehensive fibroblast functional testing improves PMD diagnosis when used complementary to genomic sequencing.